ResMedRMD
紐約證券 · USD
276.07
-1.37
(-0.49%)
盤中 08/01 01:29 (UTC+8)
08/01 01:29 (UTC+8)
ResMedRMD
276.07
-1.37
(-0.49%)
財務數據
損益表
- 10.34
- 11.17
- 11.22
- 11.02
- 11.63
- 11.97
- 12.23
- 12.25
- 12.82
- 12.92
- 8.78
- 8.04
- 0.46
- -1.76
- 5.49
- 2.94
- 2.19
- 0.11
- 4.70
- 0.75
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,291,736 | 1,282,089 | 1,224,509 | 1,223,195 | 1,196,980 | 1,162,801 | 1,102,321 | 1,122,057 | 1,116,898 | 1,033,744 |
營業成本 | 525,328 | 530,814 | 507,290 | 507,668 | 504,198 | 515,867 | 502,261 | 504,670 | 499,147 | 454,030 |
營業毛利 | 766,408 | 751,275 | 717,219 | 715,527 | 692,782 | 646,934 | 600,060 | 617,387 | 617,751 | 579,714 |
營業費用 | 340,139 | 334,033 | 329,907 | 334,311 | 318,196 | 371,840 | 311,063 | 342,118 | 317,081 | 299,521 |
研發費用 | 83,943 | 81,373 | 79,524 | 80,861 | 77,074 | 73,880 | 75,710 | 78,144 | 76,436 | 69,874 |
推銷及管理費用 | 245,302 | 241,613 | 238,979 | 242,188 | 229,919 | 222,155 | 222,874 | 240,686 | 228,457 | 210,927 |
非經常性項目費用 | - | - | - | - | - | 64,228 | - | 10,969 | - | 9,157 |
其他營業費用 | 10,894 | 11,047 | 11,404 | 11,262 | 11,203 | 11,577 | 12,479 | 12,319 | 12,188 | 9,563 |
營業利益 | 426,269 | 417,242 | 387,312 | 381,216 | 374,586 | 275,094 | 288,997 | 275,269 | 300,670 | 280,193 |
其他收入及費用 | -4,058 | 2,218 | -2,437 | -2,957 | -2,500 | -685 | 2,648 | 20,288 | -2,562 | -1,707 |
利息費用 | - | - | - | 45,708 | - | - | - | - | - | - |
稅前純益 | 417,693 | 418,323 | 383,497 | 357,732 | 375,421 | 259,454 | 272,191 | 276,802 | 289,378 | 273,691 |
所得稅 | 52,652 | 73,701 | 72,142 | 65,496 | 74,928 | 50,654 | 52,769 | 47,138 | 56,878 | 48,777 |
稅後純益 | 365,041 | 344,622 | 311,355 | 292,236 | 300,493 | 208,800 | 219,422 | 229,664 | 232,500 | 224,914 |
基本每股稅後盈餘(元) | 2.49 | 2.35 | 2.12 | 1.99 | 2.04 | 1.42 | 1.49 | 1.56 | 1.58 | - |
稀釋每股稅後盈餘(元) | 2.48 | 2.34 | 2.11 | 1.98 | 2.04 | 1.41 | 1.49 | 1.56 | 1.58 | 1.52 |
基本平均股數(千股) | 146719.00 | 146810.00 | 146861.00 | 146915.00 | 146959.00 | 147132.00 | 147075.00 | 147015.00 | 146914.00 | - |
稀釋平均股數(千股) | 147220.00 | 147481.00 | 147599.00 | 147533.00 | 147450.00 | 147545.00 | 147486.00 | 147554.00 | 147395.00 | - |
還原基本每股稅後盈餘(元) | 2.49 | 2.35 | 2.12 | 1.99 | 2.04 | 1.42 | 1.49 | 1.56 | 1.58 | - |
還原稀釋每股稅後盈餘(元) | 2.48 | 2.34 | 2.11 | 1.98 | 2.04 | 1.41 | 1.49 | 1.56 | 1.58 | 1.52 |
還原基本平均股數(千股) | 146,719 | 146,810 | 146,861 | 146,915 | 146,959 | 147,132 | 147,075 | 147,015 | 146,914 | - |
還原稀釋平均股數(千股) | 147,220 | 147,481 | 147,599 | 147,533 | 147,450 | 147,545 | 147,486 | 147,554 | 147,395 | - |
EBITDA(千元) | 469,604 | 474,225 | 437,207 | 458,195 | 430,063 | 312,824 | 325,633 | 332,001 | 342,168 | 319,230 |